Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain

Journal of Virology

Volumn 68, Issue 12, 1994, Pages 8254-8264

  Lee, Seong Wook ^a,b   Gallardo, Humilidad F ^a,b   Gilboa, Eli ^b   Smith, Clay ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; CHLORAMPHENICOL ACETYLTRANSFERASE; OLIGONUCLEOTIDE; REV PROTEIN; TRANSACTIVATOR PROTEIN; TRANSFER RNA;

ARTICLE; BINDING SITE; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE CULTURE; PRIORITY JOURNAL; PROTEIN BINDING; RNA SEQUENCE; RNA STRUCTURE; RNA TRANSCRIPTION; VIRUS INHIBITION;

EID: 0028102988     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.68.12.8254-8264.1994     Document Type: Article

References (54)

1. met gene. Nucleic Acids Res. 12:1101-1115.
2. Armentano, D., S.-F. Yu, P. Kantoff, T. von Ruden, W. Anderson, and E. Gilboa. 1987. Effect of internal viral sequences on the utility of retroviral vectors. J. Virol. 61:1647-1650.
3. Baltimore, D. 1988. Intracellular immunization. Nature (London) 335:395-396.
4. Bartel, D., M. Zapp, M. Green, and J. Szostak. 1991. HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA. Cell 67:529-536.
5. Bevec, D., M. Dobrovnik, J. Hauber, and E. Bohnlein. 1992. Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator. Proc. Natl. Acad. Sci. USA 89:9870-9874.
6. Bevec, D., B. Volc-Platzer, K. Zimmermann, M. Dobrovnik, J. Hauber, G. Veres, and E. Bobnlein. 1994. Constitutive expression of chimeric Neo-Rev response element transcripts suppresses HIV-1 replication in human CD4+ T lymphocytes. Hum. Gene Ther. 5:193-201.
7. Cheong, C., G. Varani, and J. Tinoco. 1990. Solution structure of an unusually stable RNA hairpin, 5′GGAC(UUCG)GUCC. Nature (London) 346:680-682.
8. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
9. Cochrane, A., C. Chen, and C. Rosen. 1990. Specific interaction of the human immunodeficiency virus Rev protein with a structured region in the env mRNA. Proc. Natl. Acad. Sci. USA 87:1198-1202.
10. Cook, K., G. Fisk, J. Hauber, N. Usman, T. Daly, and J. Rusche. 1991. Characterization of HIV-1 REV protein: binding stoichiometry and minimal RNA substrate. Nucleic Acids Res. 19:1577-1583.
11. Cullen, B. 1992. Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol. Rev. 56:375-394.
12. Cullen, B., and W. Greene. 1989. Regulatory pathways governing HIV-1 replication. Cell 58:423-426.
13. Dayton, E., D. Konings, D. Powell, B. Shapiro, L. Butini, J. Maizel, and A. Dayton. 1992. Extensive sequence-specific information throughout the CAR/RRE, the target sequence of the human immunodeficiency virus type 1 Rev protein. J. Virol. 66:1139-1151.
14. Duan, L., O. Bagasra, M. Laughlin, J. Oakes, and R. Pomerantz. 1994. Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody. Proc. Natl. Acad. Sci. USA 91:5075-5079.
15. Gatignol, A., A. Buckler-White, B. Berkhout, and K.-T. Jeang. 1991. Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. Science 251:1597-1600.
16. Gaynor, R., E. Soultanakis, M. Kuwabara, J. Garcia, and D. Sigman. 1989. Specific binding of HeLa cell nuclear protein to RNA sequences in the human immunodeficiency virus transactivating region. Proc. Natl. Acad. Sci. USA 86:4858-4862.
17. Gilboa, E., and C. Smith. 1994. Gene therapy for infectious diseases: the AIDS model. Trends Genet. 10:139-144.
18. Graham, G., and J. Maio. 1990. RNA transcripts of the human immunodeficiency virus transactivation response element can inhibit action of the viral transactivator. Proc. Natl. Acad. Sci. USA 87:5817-5821.
19. Hantzopoulos, P., B. Sullenger, G. Ungers, and E. Gilboa. 1989. Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector. Proc. Natl. Acad. Sci. USA 86:3519-3523.
20. Heaphy, S., J. Finch, M. Gait, J. Kara, and M. Singh. 1991. Human immunodeficiency virus type 1 regulator of virion expression, rev, forms nucleoprotein filaments after binding to a purine-rich "bubble" located within the rev-responsive region of viral mRNAs. Proc. Natl. Acad. Sci. USA 88:7366-7370.
21. Holland, S., N. Ahmad, R. Maitra, P. Wingfield, and S. Venkatesan. 1990. Human immunodeficiency virus Rev protein recognizes a target sequence in Rev-response element RNA within the context of RNA secondary structure. J. Virol. 64:5966-5975.
22. Hope, T., X. Huang, D. McDonald, and T. Parslow. 1990. Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif. Proc. Natl. Acad. Sci. USA 87:7787-7791.
23. Huang, X., T. Hope, B. Bond, D. McDonald, K. Grahl, and T. Parslow. 1991. Minimal Rev-response element for type 1 human immunodeficiency virus. J. Virol. 65:2131-2134.
24. Jaeger, J., D. Turner, and M. Zuker. 1989. Improved predictions of secondary structures for RNA. Proc. Natl. Acad. Sci. USA 86: 7706-7710.
25. Kjems, J., M. Brown, D. Chang, and P. Sharp. 1991. Structural analysis of the interaction between the human immunodeficiency virus Rev protein and the Rev response element. Proc. Natl. Acad. Sci. USA 88:683-687.
26. Le, S.-Y., M. Malim, B. Cullen, and J. Maizel. 1990. A highly conserved RNA folding region coincident with the Rev response element of primate immunodeficiency viruses. Nucleic Acids Res. 18:1613-1623.
27. Lee, S.-W., et al. Unpublished data.
28. Lee, T., B. Sullenger, H. Gallardo, G. Ungers, and E. Gilboa. 1992. Overexpression of RRE-derived sequences inhibits HIV-1 replication in CEM cells. New Biol. 4:66-74.
29. Lisziewicz, J., J. Rappaport, and R. Dhar. 1991. Tat-regulated production of multimerized TAR RNA inhibits HIV-1 gene expression. New Biol. 3:82-89.
30. Liu, J., C. Woffendin, Z.-Y. Yang, and G. Nabel. 1994. Regulated expression of a dominant negative form of Rev improves resistance to HIV replication in T cells. Gene Ther. 1:32-37.
31. Malim, M., W. Freimuth, J. Liu, T. Boyle, H. Lyerly, B. Cullen, and G. Nabel. 1992. Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication. J. Exp. Med. 176:1197-1201.
32. Malim, M., J. Hauber, R. Fenrick, and B. Cullen. 1988. Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes. Nature (London) 335:181-183.
33. Malim, M., L. Tiley, D. McCarn, J. Rusche, J. Hauber, and B. Cullen. 1990. HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence. Cell 60:675-683.
34. Marciniak, R., M. Garcia-Blanco, and P. Sharp. 1990. Identification and characterization of a HeLa nuclear protein that specifically binds to the trans-activation-response (TAR) element of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 87: 3624-3628.
35. Nara, P., and P. Fischinger. 1988. Quantitative infectivity assay for HIV-1 and -2. Nature (London) 332:469-470.
36. Olsen, H., P. Nelbock, A. Cochrane, and C. Rosen. 1990. Secondary structure is the major determinant for interaction of HIV rev protein with RNA. Science 247:845-848.
37. Rimsky, L., J. Hauber, M. Dukovich, M. Malim, A. Langlois, B. Cullen, and W. Greene. 1988. Functional replacement of the HIV-1 rev protein by the HTLV-1 rex protein. Nature (London) 335:738-740.
38. Rosen, C., and G. Pavlakis. 1990. Tat and rev: positive regulators of HIV gene expression. AIDS 4:499-509.
39. Rounseville, M., and A. Kumar. 1992. Binding of a host cell nuclear protein to the stem region of human immunodeficiency virus type 1 trans-activation-responsive RNA. J. Virol. 66:1688-1694.
40. Sanchez-Pescador, R., M. Power, P. Barr, K. Steimer, M. Stempica, S. Brown-Shimer, W. Gee, A. Renard, A. Randolph, J. Levy, D. Dina, and P. Luciw. 1985. Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). Science 227:484-492.
41. Sanford, J. 1988. Applying the PDR principle to AIDS. J. Theor. Biol. 130:469-480.
42. Sanford, J., and S. Johnston. 1985. The concept of parasite-derived resistance - deriving resistance genes from the parasite's own genome. J. Theor. Biol. 113:395-405.
43. met genes. Cell 23:699-709.
44. Sheline, C., L. Milocco, and K. Jones. 1991. Two distinct nuclear transcription factors recognize loop and bulge residues of the HIV-1 TAR RNA hairpin. Genes Dev. 5:2508-2520.
45. Shukla, R., P. Kimmel, and A. Kumar. 1994. Human immunodeficiency virus type 1 Rev-responsive element RNA binds to host cell-specific proteins. J. Virol. 68:2224-2229.
46. Sullenger, B., H. Gallardo, G. Ungers, and E. Gilboa. 1990. Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell 63:601-608.
47. Sullenger, B., H. Gallardo, G. Ungers, and E. Gilboa. 1991. Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation. J. Virol. 65:6811-6816.
48. Sullenger, B., T. Lee, C. Smith, G. Ungers, and E. Gilboa. 1990. Expression of chimeric tRNA-driven antisense transcripts renders NIH 3T3 cells highly resistant to Moloney murine leukemia virus replication. Mol. Cell. Biol. 10:6512-6523.
49. Tiley, L., S. Madore, M. Malim, and B. Cullen. 1992. The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence. Genes Dev. 6:2077-2087.
50. Tiley, L., M. Malim, H. Tewary, P. Stockley, and B. Cullen. 1992. Identification of a high affinity RNA-binding site for the human immunodeficiency virus type 1 Rev protein. Proc. Natl. Acad. Sci. USA 89:758-762.
51. Tuerk, C., P. Gauss, C. Thermes, D. Groebe, M. Gayle, N. Guild, G. Stormo, Y. Aubenton-Carafa, O. Uhlenbeck, J. Tinoco, I. Brody, and L. Gold. 1988. CUUCGG hairpins: extraordinarily stable RNA secondary structures associated with various biochemical processes. Proc. Natl. Acad. Sci. USA 85:1364-1368.
52. Vaishnav, Y., M. Vaishnav, and F. Wong-Staal. 1991. Identification and characterization of a nuclear factor that specifically binds to the Rev response element (RRE) of human immunodeficiency virus type 1 (HIV-1). New Biol. 3:142-150.
53. Yamada, O., M. Yu, J.-K. Yee, G. Kraus, D. Looney, and F. Wong-Staal. 1994. Intracellular immunization of human T cells with a hairpin ribozyme against human immunodeficiency virus type 1. Gene Ther. 1:38-45.
54. Yu, M., E. Poeschla, and F. Wong-Staal. 1994. Progress towards gene therapy for HIV infections. Gene Ther. 1:13-26.